Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
CRIPS is a research group focusing on severe acute respiratory infections and sepsis.
The objective is to develop projects on clinical and translational research in hospital-acquired pneumonia, community-acquired pneumonia, and severe viral respiratory infections, such as influenza and COVID-19. CRIPS also develop epidemiological studies focused on risk and prognostic factors for multi-resistant pathogens, validation of ventilator-associated events in ventilated adult and pediatric patients, incorporating artificial intelligence techniques. It also highlights evidence-based medicine (EBM) research, evaluating therapies and prevention strategies and participating in the formulation of clinical practice guidelines, as part of CIBERES and the European Society for Clinical Microbiology and Infections. The EBM research focuses on knowledge translation to get research findings to the point of decision making, providing health-related recommendations, focusing on clinical research and relevance of care.
CRIPS collaborate on a Local (UIC, IDIAP), National (CIBERES), and International level (CHU Nimes, Uolo University, ISARIC and Pneumo-Inspire Networks).
Publications
Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin.
PMID: 32130461
Journal: INTENSIVE CARE MEDICINE
Year: 2020
Reference: Intensive Care Med. 2020 Apr;46(4):832. doi: 10.1007/s00134-020-05986-8.
Impact factor: 17.679
Publication type: Letter or abstract
Authors: Pereira, Jose Manuel, Felton, Timothy, Dhanani, Jayesh, Roberts, Jason, Bassetti, Matteo, Welte, Tobias, Dugernier, Jonathan, Laterre, Pierre-Francois, Ehrmann, Stephan, Boisson, Matthieu et al.
DOI: 10.1007/s00134-020-05986-8
Understanding resistance in enterococcal infections.
PMID: 31792686
Journal: INTENSIVE CARE MEDICINE
Year: 2020
Reference: Intensive Care Med. 2020 Feb;46(2):353-356. doi: 10.1007/s00134-019-05875-9. Epub 2019 Dec 2.
Impact factor: 17.679
Publication type: Editorail in international publication
Authors: Rello, Jordi, Campogiani, Laura, Eshwara, Vandana Kalwaje et al.
DOI: 10.1007/s00134-019-05875-9
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).
PMID: 31781835
Journal: INTENSIVE CARE MEDICINE
Year: 2020
Reference: Intensive Care Med. 2020 Feb;46(2):245-265. doi: 10.1007/s00134-019-05866-w. Epub 2019 Nov 28.
Impact factor: 17.679
Publication type: Paper in international publication
Authors: De Waele, Jan, Shorr, Andrew F, Leone, Marc, Poulakou, Garyphallia, Depuydt, Pieter, Garnacho-Montero, Jose, Rello, Jordi, Giamarellou, Helen, Roberts, Jason A, Tabah, Alexis et al.
DOI: 10.1007/s00134-019-05866-w
Evidence supporting recommendations from international guidelines on treatment, diagnosis, and prevention of HAP and VAP in adults.
PMID: 31823149
Journal: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Year: 2020
Reference: Eur J Clin Microbiol Infect Dis. 2020 Mar;39(3):483-491. doi: 10.1007/s10096-019-03748-z. Epub 2019 Dec 10.
Impact factor: 2.837
Publication type: Paper in international publication
Authors: Campogiani, Laura, Tejada, Sofia, Ferreira-Coimbra, Joao, Restrepo, Marcos I, Rello, Jordi et al.
DOI: 10.1007/s10096-019-03748-z
News
A study, in which Vall d'Hebron has participated, has analysed all the interventions of this type carried out between 2006 and 2020.
The work of the multinational team, which has reviewed the records of more than one million patients who have received a new organ, has found significant differences between women and men
The scientific review reports that changes in the respiratory system flora due to pollution increase the risk of suffering a hospital infection caused by multidrug-resistant organisms.